Fidelity Investments on Friday sold shares of HCL Technologies worth Rs 1,788 crore through open market transactions on the National Stock Exchange (NSE).
Fidelity Investments, based in the US, divested a total of 1,24,14,228 shares, representing a 0.46 per cent stake in HCL Technologies. The shares were sold at an average price of Rs 1,440.50 per share, resulting in a deal size of Rs 1,788.27 crore.
Prominent buyers in this transaction included ICICI Prudential Mutual Fund (MF), Kotak Mahindra MF, SBI MF, Societe Generale, Morgan Stanley, Blackstone, Citigroup Global Markets Mauritius, Copthall Mauritius Investment, Ghisallo Master Fund LP, and Goldman Sachs.
HCL Technologies’ stock closed 0.42 per cent higher on Friday, settling at Rs 1,461 per share on the NSE.
In a separate transaction on the NSE, Haridas Thakarshi Kanani, a promoter of Neogen Chemicals, reduced his stake in the company by 5.6 per cent, selling shares worth Rs 241 crore. Kanani sold 14.95 lakh shares at an average price of Rs 1,611.14 per share, bringing the total transaction value to Rs 240.86 crore. This sale reduced the combined shareholding of the promoter and promoter group entities from 56.89 per cent to 51.23 per cent.
India Acorn ICAV and Custody Bank of Japan Ltd RE RB Amundi India Small Cap Equity Mother Fund acquired 10.21 lakh shares of Neogen Chemicals, while other buyers remained unidentified. Neogen Chemicals’ stock dropped 4.76 per cent to close at Rs 1,592.85 per share on the NSE.
(With PTI inputs)
